Reduced asthma onset time, mortality, inflammatory markers (BALF/peripheral blood leukocyte count, eosinophil infiltration, IL-2 and IL-4) (p < 0.05); 63 mg/kg more effective than Aminophylline at reducing onset time (p < 0.05). This evidence concerns the gene IL2 and asthma.